DXB 1.28% 38.5¢ dimerix limited

Ann: Quarterly Appendix 4C and Activities Report, page-43

  1. 634 Posts.
    lightbulb Created with Sketch. 114
    He’s just trolling.

    He’s implying that the because phase II trial had relatively few participants, it’s only really a Phase I.

    The fact is the Phase III trial is registrational and nobody is seriously doubting success will lead to an NDA / Accelerated Approval.

    The fact Advanz were prepared to sign a licensing agreement at this stage gives a lot of confidence.

    GLTAH
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.